Howard Hughes Holdings Inc., together with its subsidiaries, operates as a real estate development company in the United States.
$83.02+0.31%
报价 2026-11-13
市值
$4.96B
EV
$7.85B
PE (TTM)
28.9x
预期 PE (FY2026)
19.4x
52 周区间距高点 -7.6%
$60.22$89.85
筛选结果
pipeline · 2026-11-13Keep✓ 高增长✗ Cheap✗ GARP
Growth Pool: next 1Y revenue growth > 30%
爆发潜力
2026-11-13仅 EPS 线✗ 收入线✓ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 1.1x | 2.53 → 4.99(2.0x) | 16.6 |
| FY+32028-12 | 1.6x | 2.53 → 11.63(4.6x) | 7.1 |
毛利率 20% · TTM 收入 $2619M · 基数 EPS 2.53(调整后)
分歧大低毛利
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| HHHHoward Hughes Holdings Inc. | $4.96B | +0.3% | +78.0% | 49.4% | 28.9x | 11.2x | 5.5x | 高增长 |
| REXRRexford Industrial Realty, Inc. | $8.18B | -0.2% | -4.7% | 77.1% | – | 5759.2x | 38.4x | |
| BPYPOBrookfield Property Partners L.P. | $6.5B | -0.6% | – | 54.7% | – | 15.0x | – | |
| SBRASabra Health Care REIT, Inc. | $5.35B | +0.9% | +25.7% | 58.7% | 74.9x | 19.1x | 15.3x | GARP |
| KRGKite Realty Group Trust | $5.06B | -0.5% | -6.8% | 53.3% | 17.7x | 10.8x | 21.4x | |
| KRCKilroy Realty Corporation | $4.19B | +0.6% | -2.7% | 67% | 12.4x | 10.0x | – | |
| MRPMillrose Properties, Inc. | $3.99B | +0.8% | +37.7% | 84.8% | 10.0x | 10.5x | 0.8x | 高增长 Cheap |
| JOEThe St. Joe Company | $3.98B | -1.0% | -16.1% | 93% | 31.9x | 19.0x | 22.5x | |
| CWKCushman & Wakefield plc | $3.12B | -1.4% | +58.3% | 17.3% | 49.9x | 10.7x | 14.7x | |
| 同行中位数 | – | – | -2.7% | 62.9% | 24.8x | 12.9x | 18.3x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-09-30 Q3 2026 | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $636.3M | $1.12B | $235.9M | $624.4M | $390.2M | $260.9M | $199.3M | $983.6M |
| Gross Margin | 49.4% | 32.4% | 13.4% | -29.6% | 52.3% | 57.1% | 54.1% | 33.7% |
| Operating Margin | 24.7% | 21.3% | 21.5% | -8.3% | 48.6% | 26% | 24% | 26.5% |
| Net Income | $-1.1M | $158.4M | $8.2M | $6M | $119.5M | $-12.1M | $10.5M | $156.3M |
| Diluted EPS | -0.39 | 2.68 | 0.14 | 0.1 | 2.02 | -0.22 | 0.21 | 3.14 |
| Operating Cash Flow | $295.2M | $506.5M | $-220.2M | $360.3M | $149.8M | $177.3M | $-224.9M | $337.1M |
研究材料
Filing 摘要
暂无 filing 摘要。
电话会纪要摘要
暂无纪要摘要。